Clinical study of prostatic cancers with a PSA level of more than 100 ng/ml at the first hospital visit

Masaki Shiota, Noriaki Tokuda, Takehiro Kanou, Daisuke Yokoo, Keisuke Taniguchi, Takashi Notomi, Tsunehiro Tsukahara, Masaharu Nanri, Ken Ichi Zinnouchi

Research output: Contribution to journalArticlepeer-review

Abstract

We report the results of a clinical study of 77 patients with prostatic cancer who had a PSA level of more than 100 ng/ml at the first hospital visit between 2001 and 2005. The PSA levels ranged from 107 ng/ml to 14,455 ng/ml (median 301 ng/ml). Most of the patients had symptoms due to prostatic cancer, a high Gleason score and advanced clinical stage. Almost all the patients were treated with androgen deprivation therapy. However, many patients had PSA failure and their prognosis was poor, nevertheless, long-term PSA failure-free survival was achieved in some patients. We need to ascertain the precise prognostic marker to androgen deprivation therapy.

Original languageEnglish
Pages (from-to)1-5
Number of pages5
JournalNishinihon Journal of Urology
Volume69
Issue number1
Publication statusPublished - Jan 1 2007
Externally publishedYes

All Science Journal Classification (ASJC) codes

  • Urology

Fingerprint Dive into the research topics of 'Clinical study of prostatic cancers with a PSA level of more than 100 ng/ml at the first hospital visit'. Together they form a unique fingerprint.

Cite this